161 related articles for article (PubMed ID: 17459603)
21. Expression of the lung resistance protein in primary colorectal carcinomas.
Pohl G; Suchomel RW; Stranzl T; Depisch D; Stiglbauer W; Filipits M; Pirker R
Anticancer Res; 2001; 21(1A):201-4. PubMed ID: 11299735
[TBL] [Abstract][Full Text] [Related]
22. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
Mossink MH; van Zon A; Fränzel-Luiten E; Schoester M; Kickhoefer VA; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2002 Dec; 62(24):7298-304. PubMed ID: 12499273
[TBL] [Abstract][Full Text] [Related]
23. Expression of multidrug resistance-related markers in primary neuroblastoma.
Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
[TBL] [Abstract][Full Text] [Related]
24. Expression and proteasomal degradation of the major vault protein (MVP) in mammalian oocytes and zygotes.
Sutovsky P; Manandhar G; Laurincik J; Letko J; Caamaño JN; Day BN; Lai L; Prather RS; Sharpe-Timms KL; Zimmer R; Sutovsky M
Reproduction; 2005 Mar; 129(3):269-82. PubMed ID: 15749954
[TBL] [Abstract][Full Text] [Related]
25. On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis.
Ryu SJ; An HJ; Oh YS; Choi HR; Ha MK; Park SC
Cell Death Differ; 2008 Nov; 15(11):1673-80. PubMed ID: 18600231
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
27. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer.
Langendijk JA; Doornaert P; Rietveld DH; Verdonck-de Leeuw IM; Leemans CR; Slotman BJ
Radiother Oncol; 2009 Feb; 90(2):189-95. PubMed ID: 19167120
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity.
Kunkel M; Moergel M; Stockinger M; Jeong JH; Fritz G; Lehr HA; Whiteside TL
Oral Oncol; 2007 Sep; 43(8):796-803. PubMed ID: 17207657
[TBL] [Abstract][Full Text] [Related]
29. Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer.
Papagerakis S; Shabana AH; Pollock BH; Papagerakis P; Depondt J; Berdal A
Hum Pathol; 2009 Sep; 40(9):1320-9. PubMed ID: 19386346
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
Mosleh-Shirazi MS; Mohammadianpanah M; Mosleh-Shirazi MA
J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
[TBL] [Abstract][Full Text] [Related]
32. Age associated high level of major vault protein is p53 dependent.
An HJ; Ryu SJ; Kim SY; Choi HR; Chung JH; Park SC
Cell Biochem Funct; 2009 Jul; 27(5):289-95. PubMed ID: 19472297
[TBL] [Abstract][Full Text] [Related]
33. Bilateral neck node metastasis: a predictor of isolated distant metastasis in patients with oral and oropharyngeal squamous cell carcinoma after primary curative surgery.
Lim YC; Koo BS; Choi EC
Laryngoscope; 2007 Sep; 117(9):1576-80. PubMed ID: 17667136
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".
Porceddu SV; Rosser B; Burmeister BH; Jones M; Hickey B; Baumann K; Gogna K; Pullar A; Poulsen M; Holt T
Radiother Oncol; 2007 Dec; 85(3):456-62. PubMed ID: 18036689
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of presentation-to-diagnosis interval in patients with oropharyngeal carcinoma.
Ho T; Zahurak M; Koch WM
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):45-51. PubMed ID: 14732767
[TBL] [Abstract][Full Text] [Related]
36. MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy.
Lloret M; Lara PC; Bordón E; Rey A; Falcón O; Apolinario RM; Clavo B; Ruiz A
Gynecol Oncol; 2008 Sep; 110(3):304-7. PubMed ID: 18599112
[TBL] [Abstract][Full Text] [Related]
37. Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison.
Hodge CW; Bentzen SM; Wong G; Palazzi-Churas KL; Wiederholt PA; Gondi V; Richards GM; Hartig GK; Harari PM
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1032-41. PubMed ID: 17967300
[TBL] [Abstract][Full Text] [Related]
38. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma.
Preuss SF; Weinell A; Molitor M; Semrau R; Stenner M; Drebber U; Wedemeyer I; Hoffmann TK; Guntinas-Lichius O; Klussmann JP
Head Neck; 2008 Oct; 30(10):1318-24. PubMed ID: 18704972
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
40. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
